We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

18 hedge funds and large institutions have $25.7M invested in Tonix Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

18% less funds holding

Funds holding: 22 → 18 (-4)

41% less capital invested

Capital invested by funds: $43.7M → $25.7M (-$17.9M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.99M
2
BlackRock
BlackRock
New York
+$918K
3
State Street
State Street
Massachusetts
+$306K
4
CM
Crestline Management
Texas
+$153K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$153K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.21M
2
Prudential Financial
Prudential Financial
New Jersey
-$1.68M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$366K
4
AFM
Anson Funds Management
Texas
-$309K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$306K
Name Holding Trade Value Shares
Change 		Change in
Stake
MA
51
MONECO Advisors
Connecticut
$8K – – –
RJFSA
52
Raymond James Financial Services Advisors
Florida
$7K – – –
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$7K – – –
AIP
54
Ameritas Investment Partners
Nebraska
$6K – – –
Mackenzie Financial
55
Mackenzie Financial
Ontario, Canada
$6K – – –
Millennium Management
56
Millennium Management
New York
$6K – – –
NL
57
NVWM LLC
Pennsylvania
$6K – – –
Susquehanna International Group
58
Susquehanna International Group
Pennsylvania
$6K – – –
Prudential Financial
59
Prudential Financial
New Jersey
$5K -$1.68M -11 Closed
EH
60
Equitable Holdings
New York
$5K – – –
Fidelity Investments
61
Fidelity Investments
Massachusetts
$5K – – –
SGI
62
Summit Global Investments
Utah
$5K – – –
X
63
Xponance
Pennsylvania
$5K – – –
ETC
64
Exchange Traded Concepts
Oklahoma
$4K – – –
VHAM
65
Van Hulzen Asset Management
California
$4K – – –
BCM
66
Bridgeway Capital Management
Texas
$3K – – –
GC
67
Guggenheim Capital
Illinois
$3K – – –
Mirae Asset Global Investments
68
Mirae Asset Global Investments
South Korea
$3K – – –
PA
69
Profund Advisors
Maryland
$3K – – –
PWM
70
Purus Wealth Management
California
$3K – – –
ZIG
71
Zuckerman Investment Group
Illinois
$3K – – –
IA
72
IFP Advisors
Florida
$2K – – –
JSW
73
Journey Strategic Wealth
New Jersey
$2K – – –
SAF
74
Smith Anglin Financial
Texas
$2K – – –
SWM
75
Spire Wealth Management
Virginia
$2K – – –
1 2
3
4

TNXP Hedge Fund Activity: Q1 2022 in Review

18 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q1 2022, worth a combined $25.7M — down 41% from $43.7M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TNXP and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.99M. The largest seller was D.E. Shaw & Co, cutting an estimated $3.21M.

  • 18 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q1 2022, down from 22 in Q4 2021.
  • Funds reported $25.7M of Tonix Pharmaceuticals stock for Q1 2022, down 41% quarter-over-quarter.
  • 1 fund opened new Tonix Pharmaceuticals positions in Q1 2022 and 5 closed out, a net change of -4 holders.
  • The largest Tonix Pharmaceuticals buyer in Q1 2022 was Renaissance Technologies, an estimated $1.99M added.
  • The largest Tonix Pharmaceuticals seller in Q1 2022 was D.E. Shaw & Co, an estimated $3.21M sold.

Based on aggregated 13F filings for Q1 2022.